XML 32 R25.htm IDEA: XBRL DOCUMENT v3.25.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2025
Summary of Significant Accounting Policies [Abstract]  
Schedule of Accounts and Grants Receivable

Accounts and grants receivable by source, as of (in thousands):

 

 

June 30,
2025

 

 

December 31,
2024

 

Accounts receivable from customers

 

$

31

 

 

$

25

 

National Institutes of Health – Grant

 

 

 

 

 

59

 

Total

 

$

31

 

 

$

84

 

Schedule of Revenue

Revenue by source (in thousands):

 

 

Three months ended
June 30,

 

 

Six months ended
June 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Clinical trial revenue

 

$

298

 

 

$

287

 

 

$

557

 

 

$

802

 

Contract manufacturing lease revenue

 

 

6

 

 

 

159

 

 

 

12

 

 

 

191

 

Contract manufacturing revenue

 

 

12

 

 

 

22

 

 

 

128

 

 

 

23

 

Total

 

$

316

 

 

$

468

 

 

$

697

 

 

$

1,016